Named on one round in the feed.
Since 2023-09-25
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Magnitude Biosciences Magnitude Biosciences specializes in whole-organism high-throughput screening technologies and assays for drug discovery, serving clients in the biotech, pharma, and academic sectors. | Funding round Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $1.6M | 2023-09-25 | [ PART ] |